Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
4 studies found for:    11731939 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
Caspofungin or Micafungin as Empiric Antifungal Therapy for Persistent Fever and Neutropenia
Condition: Febrile Neutropenia
Intervention:
2 Active, not recruiting Nebulized Amphotericin B Lipid Complex in Invasive Pulmonary Aspergillosis in Paediatric Patients With Acute Leukaemia
Conditions: Invasive Pulmonary Aspergillosis;   Lymphoblastic Leukaemia;   Myeloblastic Leukaemia;   Lymphoblastic Leukemia;   Myeloblastic Leukemia
Intervention: Drug: AMPHOTERICIN B
3 Completed Acetato de Caspofungin (Cancidas®) in the Treatment of Fungal Infection
Conditions: Candidiasis;   Aspergillosis
Intervention: Drug: Caspofungin
4 Completed Antifungal Use in Oncohematological Neutropenic Patients
Condition: Invader Fungal Infection
Intervention: Drug: Antifungal drug. VORICONAZOL. (VFEND®)

Indicates status has not been verified in more than two years